Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

NIH Has New Ethics Rules; Ripples Could Hurt Agency

Feb. 7, 2005

By Aaron Lorenzo

Xcyte's Shares Slump As FDA Seeks To Rework Trial Plans

Feb. 4, 2005

By Aaron Lorenzo

Xcyte's Shares Slump As FDA Seeks To Rework Trial Plans

Feb. 4, 2005

By Aaron Lorenzo

FDA Approves Nascobal After Manufacturing Issues Solved

Feb. 3, 2005

By Aaron Lorenzo

MEND Act Unveiled As Approach For Better Medicare Buying Power

Feb. 3, 2005

By Aaron Lorenzo

MEND Act Unveiled As Approach For Better Medicare Buying Power

Feb. 3, 2005

By Aaron Lorenzo

FDA Approves Nascobal After Manufacturing Issues Solved

Feb. 3, 2005

By Aaron Lorenzo

Manufacturing Issue Slows Down Timeline For Decision On Surfaxin

Feb. 2, 2005

By Aaron Lorenzo

Drug manufacturing issues caused investors to dump shares of Discovery Laboratories Inc., dropping the company's stock price by 22 percent Tuesday. (BioWorld Today)

Manufacturing Issue Slows Down Timeline For Decision On Surfaxin

Feb. 2, 2005

By Aaron Lorenzo

Drug manufacturing issues caused investors to dump shares of Discovery Laboratories Inc., dropping the company's stock price by 22 percent Tuesday. (BioWorld Today)

$12M Private Funding To Help CepTor Push Myodur Program

Feb. 1, 2005

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 27, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 27, 2025
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...
In monkeys, enhanced TB vaccine dissolves after inducing protection
BioWorld Science
An experimental tuberculosis (TB) vaccine with a dual mission – self-destruction after inducing immunity – improved the design of the Bacillus Calmette-Guérin...
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...